CEMI News and Press, Chembio Diagnostics Inc. From 11/07/19

Chembio Diagnostics (NASDAQ: CEMI ): Q3 GAAP EPS of -$0.22 misses by $0.05 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended September 30, 2019. Recent Accomplishments & Highlights A...

Acquisition will expand commercial presence and market opportunity in Brazil MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has entered into a...

MEDFORD, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) -- November 4, 2019 - Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its SURE CHECK HIV Self-Test has received World Health Organization (WHO) Prequalificatio...

MEDFORD, NY, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter of 2019 after the close of trading on Thursday, N...

MEDFORD, N.Y., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its manufacturing facility in Malaysia has been qualified by the World Health Organization (WHO) Prequalific...

Thinly traded micro cap Chembio Diagnostics ( CEMI +12.6% ) is up on below-average volume, a modest 23K shares, on the heels of the company's announcement that it has closed a four-year $20M term loan with an affiliate of institutional investor Perceptive Advisors. More news on: Chembi...

MEDFORD, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the closing of a $20 million term loan with an affiliate of Perceptive Advisors, one of the world’s ...

MEDFORD, N.Y., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company plans to participate in two upcoming investor conferences. Management is scheduled to partici...

The following slide deck was published by Chembio Diagnostics, Inc. in conjunction with this Read more ...